Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/26558
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | COSEMANS, Charlotte | - |
dc.contributor.author | OBEN, Bénedith | - |
dc.contributor.author | ARIJS, Ingrid | - |
dc.contributor.author | Daniels, Annick | - |
dc.contributor.author | DECLERCQ, Jeroen | - |
dc.contributor.author | VANHEES, Kimberly | - |
dc.contributor.author | FROYEN, Guy | - |
dc.contributor.author | MAES, Brigitte | - |
dc.contributor.author | MEBIS, Jeroen | - |
dc.contributor.author | RUMMENS, Jean-Luc | - |
dc.date.accessioned | 2018-08-02T13:49:12Z | - |
dc.date.available | 2018-08-02T13:49:12Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 18(4), p. 235-248 | - |
dc.identifier.issn | 2152-2650 | - |
dc.identifier.uri | http://hdl.handle.net/1942/26558 | - |
dc.description.abstract | Multiple myeloma (MM), characterized by malignant plasma cells in the bone marrow, is consistently preceded by asymptomatic premalignant stage monoclonal gammopathy of undetermined significance (MGUS). These MGUS patients have an annual risk of 1% to progress to MM. Clinical, imaging, and genomic (genetic and epigenetic) factors were identified, whose presence increased the risk of progression from MGUS to MM. In this systematic review we summarize the currently identified clinical, imaging, and genomic biomarkers suggested to increase the progression risk or shown to be differentially expressed/present between both cohorts of patients. Despite the wide range of proposed markers, there are still no reliable biomarkers to individually predict which MGUS patient will progress to MM and which will not. Research on biomarkers in the progression from MGUS to MM will give more insight in the unknown pathogenesis of this hematological malignancy. This would improve research by elucidating new pathways and potential therapeutic targets as well as clinical management by closer follow-up and earlier treatment of high-risk MGUS patients. (C) 2018 Elsevier Inc. All rights reserved. | - |
dc.description.sponsorship | This project was supported by the Limburg Clinical Research Program UHasselt-ZOL-Jessa, the foundation Limburg Sterk Merk, Hasselt University, Ziekenhuis Oost-Limburg, and Jessa Hospital. | - |
dc.language.iso | en | - |
dc.rights | (C) 2018 Elsevier Inc. All rights reserved. | - |
dc.subject.other | biological marker; disease progression; hematological malignancy; premalignant stage; risk factors | - |
dc.title | Prognostic Biomarkers in the Progression From MGUS to Multiple Myeloma: A Systematic Review | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 248 | - |
dc.identifier.issue | 4 | - |
dc.identifier.spage | 235 | - |
dc.identifier.volume | 18 | - |
local.bibliographicCitation.jcat | A1 | - |
dc.description.notes | Oben, B (reprint author), Stadsomvaart 11, B-3500 Hasselt, Belgium, benedith.oben@uhasselt.be | - |
local.type.refereed | Refereed | - |
local.type.specified | Review | - |
dc.identifier.doi | 10.1016/j.clml.2018.02.011 | - |
dc.identifier.isi | 000428862400005 | - |
item.fulltext | With Fulltext | - |
item.contributor | COSEMANS, Charlotte | - |
item.contributor | OBEN, Bénedith | - |
item.contributor | ARIJS, Ingrid | - |
item.contributor | Daniels, Annick | - |
item.contributor | DECLERCQ, Jeroen | - |
item.contributor | VANHEES, Kimberly | - |
item.contributor | FROYEN, Guy | - |
item.contributor | MAES, Brigitte | - |
item.contributor | MEBIS, Jeroen | - |
item.contributor | RUMMENS, Jean-Luc | - |
item.accessRights | Open Access | - |
item.fullcitation | COSEMANS, Charlotte; OBEN, Bénedith; ARIJS, Ingrid; Daniels, Annick; DECLERCQ, Jeroen; VANHEES, Kimberly; FROYEN, Guy; MAES, Brigitte; MEBIS, Jeroen & RUMMENS, Jean-Luc (2018) Prognostic Biomarkers in the Progression From MGUS to Multiple Myeloma: A Systematic Review. In: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 18(4), p. 235-248. | - |
item.validation | ecoom 2019 | - |
crisitem.journal.issn | 2152-2650 | - |
crisitem.journal.eissn | 2152-2669 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
cosemans 1.pdf Restricted Access | Published version | 331.99 kB | Adobe PDF | View/Open Request a copy |
cosemans2018.pdf | Peer-reviewed author version | 1.45 MB | Adobe PDF | View/Open |
SCOPUSTM
Citations
5
checked on Sep 3, 2020
WEB OF SCIENCETM
Citations
9
checked on Apr 23, 2024
Page view(s)
62
checked on Jun 14, 2022
Download(s)
470
checked on Jun 14, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.